MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$277,925
Unit: Dollar
Positive Cash Flow Breakdown
Contingent liabilities
Accrued expenses and other liabi...
Prepaid expenses
Others
Negative Cash Flow Breakdown
Net loss from continuing operati...
Repayment of loans
Change in fair value of earnout ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss from continuing operations
-1,883,290
-1,431,713
-2,083,222
-4,822,060
Stock-based compensation
78,759
145,927
193,712
189,926
Depreciation and amortization of intangible assets
13,338
15,038
16,271
16,268
Amortization of right of use assets
22,746
22,282
21,826
114,553
Change in fair value of earnout liabilities
-55,996
-96,053
-93,110
-56,474
Inventory write-down
38,917
196,684
13,881
47,082
Accounts receivable
-29,119
12,165
-10,022
-7,974
Inventory
-89,383
-31,376
-36,459
-112,184
Prepaid expenses
-115,717
-101,532
-129,168
-87,421
Income taxes receivable
-
-
-301,838
-
Accounts payable
-6,471
551,354
323,824
-455,757
Accrued expenses and other liabilities
184,368
15,112
845,599
77,816
Contingent liabilities
1,174,155
-
-
-
Lease liability
-24,626
-24,665
-22,635
-22,190
Net cash used in operating activities
-223,881
-485,291
-306,367
-1,433,756
Cash paid for elevai acquisition transaction costs
0
-
0
0
Purchases of property and equipment
-
-
1
14,224
Cash paid for offering costs
0
-
-
-
Net cash used in investing activities
0
-
-1
776
Proceeds from issuance of common stock, net of costs
0
190,001
0
86,314
Proceeds from exercise of common stock warrants
-
-
0
1,000,000
Proceeds from short-term borrowings
50,000
-
-
-
Repayment of loans
104,044
98,054
96,120
95,305
Net cash provided by financing activities
-54,044
91,947
-96,120
991,009
Net (decrease) increase in cash and cash equivalents
-277,925
-393,344
-402,488
952,089
Cash and cash equivalents - beginning of period
313,396
706,740
1,109,228
157,139
Cash and cash equivalents - end of period
35,471
313,396
706,740
1,109,228
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net (decrease)
increase in cash and cash...
-$277,925
Contingent liabilities
$1,174,155
Accrued expenses and
other liabilities
$184,368
(-68.88%↓ Y/Y)
Prepaid expenses
-$115,717
(63.96%↑ Y/Y)
Inventory
-$89,383
(59.78%↑ Y/Y)
Stock-based compensation
$78,759
(-74.52%↓ Y/Y)
Inventory write-down
$38,917
Accounts receivable
-$29,119
(-11.33%↓ Y/Y)
Amortization of right of use
assets
$22,746
(-75.59%↓ Y/Y)
Depreciation and
amortization of intangible...
$13,338
(-71.09%↓ Y/Y)
Proceeds from short-term
borrowings
$50,000
Net cash used in
operating activities
-$223,881
(85.91%↑ Y/Y)
Net cash provided by
financing activities
-$54,044
(-101.72%↓ Y/Y)
Canceled cashflow
$1,746,502
Canceled cashflow
$50,000
Net loss from
continuing operations
-$1,883,290
(44.48%↑ Y/Y)
Repayment of loans
$104,044
(-58.26%↓ Y/Y)
Change in fair value of
earnout liabilities
-$55,996
(-288.98%↓ Y/Y)
Lease liability
-$24,626
(74.27%↑ Y/Y)
Accounts payable
-$6,471
(-102.50%↓ Y/Y)
Buy us a coffee
Longevity Health Holdings, Inc. (XAGEW)
Longevity Health Holdings, Inc. (XAGEW)